“Clearly, the mutants have a reducing effect on the efficacy of the vaccines. We see that we are going to be challenged. ”– Dr Anthony Fauci, director of the National Institute of Allergies and Infectious Diseases.
Pfizer Chief Executive Albert Bourla says there is a “high potential” that changes that may emerge at some point could render Pfizer’s vaccine ineffective. “This is not yet the case … but I think it is very likely that that will happen one day,” said Bourla at the World Economic Forum.
“It is a different pandemic now. ” – Dr. Dan Barouch who helped develop the J&J vaccine is a researcher at Harvard School’s Beth Israel Deaconess Medical Center in Boston.
I have expressed my disappointment with directors not playing nice. However, as data begins to show that routine vaccines are less effective on new ones, the stakes continue to rise, and the game becomes even more so. This new information reinforces the urgency of getting people vaccinated as quickly and effectively as possible. And yet, our world leaders refuse to play nice.
According to preliminary data, in test participants in South Africa where the new mutations are known to be more powerful more widely, it was found that the Novavax Inc and Johnson & Johnson vaccines were not significantly lower in inhibits COVID-19.
- On Thursday Novax reported that their median test results on humans in South Africa showed that the vaccine has an overall effectiveness of 50% in preventing COVID-19.
- End-of-period results from the UK showed that the vaccine was up to 89.3% effective in preventing COVID19.
- Johnson & Johnson has stated that a test spread across three continents showed that one vaccine view achieved an overall efficiency of 66%. However, there were significant differences by area. In South Africa where 95% of reported cases involved variable results B 1.351 showed an efficiency level of 57% vs. USA, where the new changes are believed to be smaller *, showing an overall efficiency of 72%.
- It is unknown how the Pfizer Inc. vaccine will work. and the BioNTech vaccine, as well as the Moderna Inc vaccine, perform against the new variables because the tests that showed 95% efficacy were mostly performed in the U.S. before the mutations were identified.
- Two cases of the new B.1.351 South African variant have now been reported in South Carolina, USA.
- Although the vaccine may no longer be as effective in preventing cases, the J&J vaccine has been shown to be 89% effective in preventing severe cases of COVID-19. in South Africa.
That being said, the reduced effectiveness does not diminish the vital role that vaccines play in our fight against the pandemic. Of course, it only confirms.
“The final game is to stop deaths, to stop hospitals from going into crisis – and it seems that all of these vaccines, even including against the South African variety, are , does just that, ”said Dr Amesh Adalja, an infectious disease specialist at the Johns Hopkins Center for Health Security
“The best way to prevent further evolutionary viruses is to prevent reproduction,” Fauci said, “and you can do that by vaccinating humans as soon as you can.”
The stakes were built. The ante has gone up. Every dose of vaccine has the power to save lives. Ensuring a fair global distribution should be paramount. Not only is fair circulation morally correct, but, it is also just wise.
As we all know, our supply chains are now global interdependent networks. Vaccines are made in one country using raw materials from another country. Playing dirty by restricting vaccine exports could harm those who want self-service.
Something that seems like Germany may have forgotten. More on that next.